Pre-trial quality assurance processes for an intensity-modulated radiation therapy (IMRT) trial: PARSPORT, a UK multicentre Phase III trial comparing conventional radiotherapy and parotid-sparing IMRT for locally advanced head and neck cancer.

The purpose of this study was to compare conventional radiotherapy with parotid gland-sparing intensity-modulated radiation therapy (IMRT) using the PARSPORT trial. The validity of such a trial depends on the radiotherapy planning and delivery meeting a defined standard across all centres. At the outset, many of the centres had little or no experience of delivering IMRT; therefore, quality assurance processes were devised to ensure consistency and standardisation of all processes for comparison within the trial. The pre-trial quality assurance (QA) programme and results are described. Each centre undertook exercises in target volume definition and treatment planning, completed a resource questionnaire and produced a process document. Additionally, the QA team visited each participating centre. Each exercise had to be accepted before patients could be recruited into the trial. 10 centres successfully completed the quality assurance exercises. A range of treatment planning systems, linear accelerators and delivery methods were used for the planning exercises, and all the plans created reached the standard required for participation in this multicentre trial. All 10 participating centres achieved implementation of a comprehensive and robust IMRT programme for treatment of head and neck cancer.

[1]  M. Robinson,et al.  The role of intensity-modulated radiotherapy in the treatment of parotid tumors. , 2002, International journal of radiation oncology, biology, physics.

[2]  A. Poynter,et al.  Practical experience with intensity-modulated radiotherapy. , 2004, The British journal of radiology.

[3]  R Mohan,et al.  Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and neck cancers. , 2000, International journal of radiation oncology, biology, physics.

[4]  R. Mackay,et al.  Quantitative analysis of patient-specific dosimetric IMRT verification , 2005, Physics in medicine and biology.

[5]  V Grégoire,et al.  Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[6]  S C Lillicrap,et al.  Code of Practice for high-energy photon therapy dosimetry based on the NPL absorbed dose calibration service , 1990 .

[7]  D. Dearnaley,et al.  Questionnaire based quality assurance for the RT01 trial of dose escalation in conformal radiotherapy for prostate cancer (ISRCTN 47772397). , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[8]  Kevin J Harrington,et al.  Assessment of a customised immobilisation system for head and neck IMRT using electronic portal imaging. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  S. Dische,et al.  Quality assurance in the CHART clinical trial. , 1995, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  D. Lefkopoulos,et al.  Programme commun d'assurance de qualité de la radiothérapie conformationnelle avec modulation d'intensité (RCMI) des cancers de la tête et du cou , 2003 .

[11]  S. Webb,et al.  Optimisation of radiotherapy for carcinoma of the parotid gland: a comparison of conventional, three-dimensional conformal, and intensity-modulated techniques. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[12]  P. Hoskin,et al.  A survey of radiotherapy quality control practice in the United Kingdom for the START trial. , 2001, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[13]  A. Nahum,et al.  The IPEMB code of practice for electron dosimetry for radiotherapy beams of initial energy from 2 to 50 MeV based on an air kerma calibration. Institution of Physics and Engineering in Medicine and Biology. , 1996, Physics in medicine and biology.

[14]  A. Eisbruch,et al.  Parotid Sparing Study in Head and Neck Cancer Patients Receiving Bilateral Radiation Therapy: One-year Results , 1997, Journal of dental research.

[15]  D. Dearnaley,et al.  Target volume definition for head and neck intensity modulated radiotherapy: pre-clinical evaluation of PARSPORT trial guidelines. , 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

[16]  Sofia Zefkili,et al.  Recommandations pour un protocole d’assurance de qualité de la radiothérapie conformationnelle avec modulation d’intensité des cancers de la tête et du cou , 2004 .

[17]  D. Dearnaley,et al.  IMRT clinical implementation: Prostate and pelvic node irradiation using Helios and a 120‐leaf multileaf collimator , 2002, Journal of applied clinical medical physics.

[18]  A. Eisbruch,et al.  The influence of pre-radiation salivary flow rates and radiation dose on parotid salivary gland dysfunction in patients receiving radiotherapy for head and neck cancers. , 1998, Special care in dentistry : official publication of the American Association of Hospital Dentists, the Academy of Dentistry for the Handicapped, and the American Society for Geriatric Dentistry.

[19]  M R McEwen,et al.  The IPEM code of practice for electron dosimetry for radiotherapy beams of initial energy from 4 to 25 MeV based on an absorbed dose to water calibration. , 2003, Physics in medicine and biology.

[20]  R Mohan,et al.  The potential for sparing of parotids and escalation of biologically effective dose with intensity-modulated radiation treatments of head and neck cancers: a treatment design study. , 2000, International journal of radiation oncology, biology, physics.

[21]  Cedric X. Yu,et al.  Guidance document on delivery, treatment planning, and clinical implementation of IMRT: report of the IMRT Subcommittee of the AAPM Radiation Therapy Committee. , 2003, Medical physics.

[22]  T. Pawlicki,et al.  The MLC tongue-and-groove effect on IMRT dose distributions , 2000, Proceedings of the 22nd Annual International Conference of the IEEE Engineering in Medicine and Biology Society (Cat. No.00CH37143).

[23]  K. Ang,et al.  CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC,RTOG consensus guidelines. , 2003, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[24]  Marcel van Herk,et al.  Observer variation in target volume delineation of lung cancer related to radiation oncologist-computer interaction: a 'Big Brother' evaluation. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[25]  Sha X. Chang,et al.  Beam orientation selection for intensity-modulated radiation therapy based on target equivalent uniform dose maximization. , 2001, International journal of radiation oncology, biology, physics.

[26]  P. Hoskin,et al.  Survey of UK breast radiotherapy techniques: background prior to the introduction of the quality assurance programme for the START (standardisation of radiotherapy) trial in breast cancer. , 2002, Clinical oncology (Royal College of Radiologists (Great Britain)).

[27]  D. Dearnaley,et al.  The impact of introducing intensity modulated radiotherapy into routine clinical practice. , 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[28]  R K Ten Haken,et al.  Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. , 1999, International journal of radiation oncology, biology, physics.

[29]  D. Low,et al.  A technique for the quantitative evaluation of dose distributions. , 1998, Medical physics.

[30]  I. Rosen,et al.  Implementing IMRT in clinical practice: a joint document of the American Society for Therapeutic Radiology and Oncology and the American Association of Physicists in Medicine. , 2004, International journal of radiation oncology, biology, physics.

[31]  K. Harrington,et al.  Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[32]  Intensity-Modulated Radiotherapy: First Results with this New Technology on Neoplasms of the Head and Neck , 1999, Ear, nose, & throat journal.

[33]  Steve Webb,et al.  Clinical implementation of dynamic and step-and-shoot IMRT to treat prostate cancer with high risk of pelvic lymph node involvement. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.